You can buy or sell ALXN and other stocks, options, ETFs, and crypto commission-free!
Alexion Pharmaceuticals, Inc. Common Stock, also called Alexion Pharmaceuticals, is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Read More Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA. The listed name for ALXN is Alexion Pharmaceuticals, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Oct 21, Pre-Market